Vivek Narayan

17PUBLICATIONS
135CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRadiation therapyCardiology (incl. cardiovascular diseases)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 20, 2026
Cluster Randomized Controlled Trial of Intensive Systolic Blood Pressure Control in Patients With Renal Cell or Thyroid Cancer Receiving VEGFR Tyrosine Kinase Inhibitors: ECOG-ACRIN EAQ191.

|Apr 21, 2026
B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities Across Prostate Cancer Patient Groups.

|Mar 04, 2026
131I-LNTH-1095 Radioligand Therapy plus Enzalutamide versus Enzalutamide Alone in Men with PSMA-Avid Metastatic Castration-Resistant Prostate Cancer: A Phase II Study.

Evan Y Yu, Vivek Narayan, Giuseppe Esposito

|Oct 26, 2025
HLA class I expression shapes the tumor immune microenvironment and influences prognosis in prostate cancer.

Pornlada Likasitwatanakul, Carissa Besonen, Alexander K Tsai

|Aug 12, 2025
Correction: Natural killer cell infiltration in prostate cancers predict improved patient outcomes.

Nicholas A Zorko, Allison Makovec, Andrew Elliott

|Jan 25, 2025
Enhancing Radiation Therapy Response in Prostate Cancer Through Metabolic Modulation by Mito-Lonidamine: A <sup>1</sup>H and <sup>31</sup>P Magnetic Resonance Spectroscopy Study.

Stepan Orlovskiy, Pradeep Kumar Gupta, Fernando Arias-Mendoza

Pageof 3

Frequent Collaborators

5 joint publications

Naomi Balzer-Haas

4 joint publications

Nicholas A Zorko

4 joint publications

Emmanuel S Antonarakis

3 joint publications

Allison Makovec